Article
Fludarabine and cytarabine versus high-dose cytarabine in consolidation treatment of t(8; 21) acute myeloid leukemia: A prospective, randomized study.
American journal of hematology - 1 Jan 2017
Li Ruiqi, Hu Xiaoxia, Wang Libing, Cheng Hui, Lv Shuqing, Zhang Weiping, Wang Jianmin, Yang Jianmin, Song Xianmin
Abstract excerpt
Acute myeloid leukemia (AML) patients with t(8;21) aberration often have favorable outcomes, however, relapse still occurs in 30-40% patients, with only 50-60% of patients with t(8;21) AML cured with regimens containing high-dose cytarabine (HD-Ara-C). To evaluate the effects of fludarabine and cytarabine (FA) consolidation therapy for t(8;21) AML patients, a prospective randomized study was performed. A total of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
